NVID INTERNATIONAL INC/DE
10SB12G, EX-10.2, 2000-09-25
BLANK CHECKS
Previous: NVID INTERNATIONAL INC/DE, 10SB12G, EX-10.1, 2000-09-25
Next: NVID INTERNATIONAL INC/DE, 10SB12G, EX-10.3, 2000-09-25



                              EX-10.2
                              Licensing Agreement dated Novemeber 10, 1998


                                      122
<PAGE>

                            EXHIBIT 10.2

 This Agreement is given on the 10thday of November 1998

BETWEEN

EHPC  IONISATION  LIMITED a company  incorporated  under the laws of England and
Wales under company number 03541625 whose registered  offices are located at 87a
Newington Causeway, London se1 6DH (t Hereinafter known as the Licensor) AND

(1) WALLACE AND TIERNAN LIMETED a company incorporated under the laws of England
and Wales under company number 021 2577 whose registered  offices are located at
Priory Works, Tudley Lane,  Tonbridge,  Kent TN 11 0QL (Hereinafter known as the
Licensee) (2) USF LIMITED a company  incorporated  under the laws of England and
Wales  under  company  number  426414  whose  registered  offices are located at
Whittle Road, Meir Stoke on Trent, Staffs ST3 7020

1.       The Parties agree to develop the Ionisation Non Halogen Disinfecting
         system in accordance with the Development Programme.

2.       a) EHPCI agrees to provide to USF for the  purposes of the  Development
         Programme  and to the  extent  the  Parties  agree  is  necessary,  the
         research  services  of Major  Randy Reid at EHPCI's  facility  al Lyons
         House, 2 Station Road, Frimley. Camberley, Surrey 4U18 S.HF and also at
         a place  or  places  to be  nominated  by USF for the  purposes  of the
         Development.

         b)USF shall pay t0 EHPCI a Research and Development Fee of(pound)30,000
         at(pound)10,000 per month.

3.       Each Party shall fund its participation in the development of the
         ionisation Non Halogen Disinfecting System.

4.       The period for the carrying out of the Development Programme shall
         commence on the date of signature  of this  Agreement  and expire three
         months later or on such other  date  as the  Parties  agree  to in
         writing, which period is whereinafter called the "Development Period".

5.       The Parties will meet at the following times:

         a)       every month  during the  duration of the  Development  Period
         in order to discuss and evaluate the progress of the Development
         Technology Know-how. EHPCI shall have the right to request additional
         meetings upon reasonable notice to USF;

         b)       within  thirty  (30) days of the expiry of the  Development
         Period and  determine  the  success or failure of the Development
         Programme.

6.       Neither Party will make any use of the disclosure of the  Development
         Programme  Technology  Know-How  without the written consent of the
         other.

7.       The Parties agree that in the event of termination of  this Agreement,
         EHPCI shall have  the right to Purchase the Development  Programme
         Technology Know-how from USF for a reasonable sum subject to a maximum
         (pound)30.000  including those parts of the Development  programme
         Technology  Know-how  which are created by USF and those parts which
         are not  dependent  on the  Technology  Know-How  end to exploit the
         Development Programme Technology Know-How at its absolute discretion.


                                      123
<PAGE>



8.       The Parties further  agree that USF shall, for their own benefit use,
         the Anodes In respect of the Product arid the Development Programme
         Technology Know-How Development

9.       IMPROVEMENTS

         9.1      During the Term:

                  a) EHPCI will disclose to USF Improvements made by EHPCI which
                  upon  disclosure will be deemed to form part of the Technology
                  Know-How and subject to the Licence,  and by USF will disclose
                  to EHPCI  Improvements  made by USF and  apply the same to the
                  prosecution  of  the  Licence.  USF  hereby  grants  EHPCI  on
                  Exclusive  licence to use such  Improvements  in its course of
                  business.

                  b) USF acknowledges and agrees that the Improvements described
                  in clause 9.1a and  Intellectual  Property  rights  subsisting
                  therein  vest  in  EHPCI  and  Mat  upon  termination  of this
                  Agreement  by EHPCI in any event,  may be  exploited  by EHPCI
                  alone or with third  parties  in such ways as EHPCI  deems tit
                  without account to USF.

EXECUTED BY THE PARTIES IN THIS AGREEMENT

Signed for and on behalf of:

EHPCI LTD

USF LIMITED



                                      124
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission